Continuing the Success of Journal of Endocrinology and Journal of Molecular Endocrinology

244 1

Journal of S Andrikopoulos et al. Continuing the success of 244:1 E1–E2 Endocrinology JOE and JME EDITORIAL Continuing the success of Journal of Endocrinology and Journal of Molecular Endocrinology

S Andrikopoulos1, C Farquharson2 and M Haluzik3

1Department of Medicine, University of Melbourne, Parkville, Victoria, Australia 2University of Edinburgh-Roslin Institute, Edinburgh, UK 3Diabetes Centre, Institute for Clinical and Experimental Medicine and Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic Journal of Endocrinology Correspondence should be addressed to S Andrikopoulos: [email protected] (2020) 244, E1–E2

Message from the outgoing Co-Editor-in-Chief

I cannot believe how quickly time has passed, as it has much effort into ensuring that the profiles of JOE and been over 4 years since I took over the Editor-in-Chief JME are prominent, by engaging with other societies, role of Journal of Endocrinology and Journal of Molecular as well as being present at and supporting international Endocrinology (JOE and JME) from Adrian Clark. At scientific meetings. Naturally, in the age of social media that time, the editorial boards had just merged and the the publishing team has established profiles for the senior editorial team was getting settled into handling journals on Facebook and Twitter, and I encourage you manuscripts for two journals. all to use these platforms to engage with the content of So what have we achieved over the past 4 years or the journals. so? We have implemented a Co-Editor-in-Chief structure, Publishing continues to be a competitive space with with Prof. Colin Farquharson and I sharing the load of more and more journals being created, competing both triaging and assigning every manuscript that is submitted for manuscripts and for reviewer time. Despite this, I am to JOE and JME. I am pleased to state that the senior pleased to say that we have maintained our high standards editorial team has been extremely hard working and and continue to receive and publish excellent research. supportive of both Colin and I, ensuring timely and I am confident that this will ensure the reputations of balanced decision making for each manuscript which is JOE and JME are maintained and secure their long-term being reviewed. This is reflected in the time taken from relevance in the field. submission to first decision being 15 days for JOE and I have thoroughly enjoyed my time with the 18 days for JME. In addition, the 2018 author survey journals, progressing up the ranks from reviewer to editor, showed 65% of respondents rated their experience with senior editor to deputy Editor-in-Chief, to finally being JOE and JME as better, or much better, compared with entrusted with the top job. I have particularly enjoyed other journals. Finally, the impact factors of both JOE and working closely with Colin as Co-Editors-in-Chief, JME remain very strong at 4.381 and 3.744 respectively, with the senior editorial team and with Alison Pope at reflecting the excellent scientific content of our journals. Bioscientifica. Despite some personal and professional These data are satisfying and reflect the enormous input challenges, the support and help I received from all these and efforts of both the senior editorial group and the team people has allowed me to devote 110% to my role. I am at Bioscientifica. sad to say goodbye. However, I am extremely happy We continue to grow the international reputation that Prof. Martin Haluzik from the Czech Republic has of the journals and this is highlighted by increased agreed to replace me. Martin is an outstanding clinician submissions from Asia, Europe, North America and researcher and his experience and knowledge will be most Australia/New Zealand. Furthermore, the senior editorial valuable to the journals. I wish both Colin and Martin all board reflects this distribution, with representation from the best as they continue to drive both JOE and JME to China, Singapore, the USA, Australia and New Zealand higher heights. in addition to the UK and Europe. We continue to put Sof Andrikopoulos

https://joe.bioscientifica.com © 2020 Society for Endocrinology https://doi.org/10.1530/JOE-19-0504 Published by Bioscientifica Ltd. Printed in Great Britain Downloaded from Bioscientifica.com at 09/30/2021 08:32:19AM via free access

-19-0504 Journal of S Andrikopoulos et al. Continuing the success of 244:1 E2 Endocrinology JOE and JME

Message from the incoming and Society of Australia members, and is free for Society for current Co-Editors-in-Chief Endocrinology members. We continue to explore novel ways to encourage Due to the ever increasing submissions to JOE and JME, research submissions from the global research community. it was decided that from January 2018 the journals would Working closely with our Associate Editors situated in all have two Editors-in-Chief, and it has been my privilege corners of the globe, we aspire to increase the geographical [Colin Farquharson] to serve alongside Sof Andrikopoulos coverage of our submissions, reflecting the developing in this role. Prior to 2018, Sof had expertly guided both spread of endocrine excellence. In particular, we welcome journals and overseen increases in manuscript submissions and encourage submissions from our colleagues in worldwide, which resulted in both journals increasing Africa, the Middle East and Australasia, whilst striving to their impact factor in 2018: JOE re-established itself in maintain our submission rates from elsewhere including the top quartile of the Endocrinology & Metabolism Asia which remains the region with the highest number category, with JME maintaining its place. Sof has left of submissions. both journals in an excellent position for them to move For several years the journals have supported and forward with optimism, and we both thank him greatly sponsored endocrine-based meetings and workshops for his dedication, innovation and hard work in helping throughout the world, and we reward authors publishing make both journals what they are today. From January in both journals with prizes at our annual Society for 2020, Martin Haluzik will replace Sof as Co-Editor-in- Endocrinology meetings. We also continue with our Chief and he will handle all submissions within the field special anniversary issues, which celebrate the major of Diabetes, Metabolism and Obesity. We are indebted to achievements and milestones in endocrinology: in 2020 Barbara Clark, our Deputy Editor who, among other roles JME will publish a number of reviews to celebrate 90 Years will continue to have oversight of our review portfolio of Progesterone. This issue will be guest edited by Profs which makes up a significant percentage of our published Simak Ali and Bert O’Malley. material, thereby contributing to the continued success of So we look forward, with optimism, to producing two both journals. high-quality journals for the Society for Endocrinology, We are acutely aware that authors within our field which capture the most exciting and novel breakthroughs have an ever-increasing choice of online journals in in endocrine basic and translational science. Whilst we which to submit their research manuscripts. However, continue to encourage publications in all traditional and we believe that the international reputation for quality developing fields of endocrine enquiry, in the next few and scientific rigour of our journals, together with years we will have a particular focus on cardiovascular, continued hard work from the editorial team and our renal and neurometabolism submissions for JOE, Bioscientifica publishing colleagues, will help us in our and omics, hormone-dependent cancers and nuclear aim to maintain both journals as the preferred choice of receptors for JME. In addition to the traditional focus authors for their valued manuscripts. In return, we offer on experimental research, we encourage submissions them a rapid decision from submission to first response. from translational research areas, including studies in We also strive to give a fair review, and to provide humans that specifically address the pathophysiological authors with constructive and informative feedback mechanisms of endocrine and metabolic diseases. in order to improve their manuscripts. We continue to The journals have now served the endocrine demand no submission fees, no page charges and no community for 80 years and we look forward with charges for online-only colour figures from our authors. enthusiasm to continuing this mission during our joint Furthermore, colour print production is discounted stewardship. for European Society of Endocrinology and Endocrine Colin Farquharson and Martin Haluzik

Received in final form 30 October 2019 Accepted 30 October 2019